Medical News Business

No new concerns with use of Fabiflu: Glenmark study

Rohit Shishodia

Post-marketing surveillance (PMS) study on Favipiravir (Fabiflue) conducted by Glenmark has found no new safety signals or concerns with the use of the drug on mild to mo

Zydus gets tentative USFDA nod to sell Sitagliptin

DTMT Network

Zydus Cadila, a global pharmaceutical company, has informed that it has received tentative approval from the United States Food and Drug Administration (FDA) for its new drug ap

farmaci per mantenere l'erezione .

Back to Top